GPD2 and prostate carcinoma: In prostate cancer cells, study found that GPD2-associated mRNA was higher than in normal prostate epithelial cells and that upregulation of GPD2 promoted an overall increase in ROS production and likely contributed to cancer progression due to enhanced intracellular glycolysis capacity [10].